Chronic myelogenous leukemia other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
Other diagnostic studies for chronic myelogenous leukemia include [[bone marrow aspiration]] and [[biopsy]], [[lumbar puncture]], and [[lymph node biopsy]].
Other diagnostic studies for chronic myelogenous leukemia include [[bone marrow aspiration]] and [[biopsy]], [[lumbar puncture]], and [[lymph node biopsy]].


The diagnostic work-up for chronic myelogenous leukemia consists of a complete blood count, including a differential and a platelet count; marrow aspiration, with measurement of the percentage of blasts and the percentage of basophils; marrow biopsy; and cytogenetic studies for Ph and markers of karyotypic evolution. In patients who are Ph negative, molecular studies, such as Southern blot assay or polymerase chain reaction (PCR), are indicated to detect the BCR-ABL rearrangements.
The diagnostic work-up for chronic myelogenous leukemia consists of a complete blood count, including a differential and a platelet count; marrow aspiration, with measurement of the percentage of blasts and the percentage of basophils; marrow biopsy; and cytogenetic studies for Ph and markers of karyotypic evolution. In patients who are Ph negative, molecular studies, such as Southern blot assay or polymerase chain reaction (PCR), are indicated to detect the BCR-ABL rearrangements.PMID:10428738
 
PMID:
: 10428738
 
==Other diagnostic studies==
==Other diagnostic studies==
Other diagnostic studies for chronic myelogenous leukemia include:<ref name="cancer.ca">Canadian Cancer Society.2015.http://www.cancer.ca/en/cancer-information/cancer-type/leukemia-chronic-myelogenous-cml/diagnosis/?region=ab</ref>
Other diagnostic studies for chronic myelogenous leukemia include:<ref name="cancer.ca">Canadian Cancer Society.2015.http://www.cancer.ca/en/cancer-information/cancer-type/leukemia-chronic-myelogenous-cml/diagnosis/?region=ab</ref>

Revision as of 13:48, 13 May 2018

Chronic myelogenous leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic myelogenous leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic myelogenous leukemia other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic myelogenous leukemia other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic myelogenous leukemia other diagnostic studies

CDC on Chronic myelogenous leukemia other diagnostic studies

Chronic myelogenous leukemia other diagnostic studies in the news

Blogs on Chronic myelogenous leukemia other diagnostic studies

Directions to Hospitals Treating Chronic myelogenous leukemia

Risk calculators and risk factors for Chronic myelogenous leukemia other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Other diagnostic studies for chronic myelogenous leukemia include bone marrow aspiration and biopsy, lumbar puncture, and lymph node biopsy.

The diagnostic work-up for chronic myelogenous leukemia consists of a complete blood count, including a differential and a platelet count; marrow aspiration, with measurement of the percentage of blasts and the percentage of basophils; marrow biopsy; and cytogenetic studies for Ph and markers of karyotypic evolution. In patients who are Ph negative, molecular studies, such as Southern blot assay or polymerase chain reaction (PCR), are indicated to detect the BCR-ABL rearrangements.PMID:10428738

Other diagnostic studies

Other diagnostic studies for chronic myelogenous leukemia include:[1]

  • Used to detect and/or determine the type of leukemic cells
  • Used to detect and/or determine the type of leukemic cells

Gallery

References


Template:WikiDoc Sources